But when your peripheral nerves-those found outside of the brain and spinal cord-are damaged, it can cause pain and numbness ...

Grünenthal announced today that its U.S. subsidiary, Averitas Pharma, Inc., has completed recruitment for the Phase III clinical trial AV001. The trial investigates the efficacy, safety and ...

A small 2020 study involving 29 people with peripheral neuropathy looked at the effectiveness of topical CBD oil for pain. The participants were divided into two groups: a treatment group that ...

Topical analgesics, more commonly known as muscle pain relief creams ... Those with referred pain from a neuropathy or nerve issue may benefit from a CBD topical agent. Those with generalized ...

Averitas Pharma, the US subsidiary of Grünenthal, has completed patient recruitment for the Phase III AV001 clinical study, ...

There are a variety of OTC topical pain relief products: Medications for treating pain caused by osteoarthritis ... Effect of duloxetine on pain, function, and quality of life among patients with ...

Oncology Nursing News: Can you provide a brief overview on your abstract on peripheral neuropathy from SIO? Lee: So this year, at the SIO 2024 conference, our research team presented an abstract which ...

The Phase III trial AV001 aims to evaluate QUTENZA® in post- surgical neuropathic pain (PSNP), a debilitating complication of surgery occurring after ...

Sangamo Therapeutics announced that the FDA has cleared the investigational new drug application for its ST-503 program, an investigational epigenetic regul ...

Topical agents address the primary goals of RAU therapy, including reduction in ulcer pain and duration ... Extended treatment has resulted in peripheral neuropathy, a potentially irreversible ...